. Author manuscript; available in PMC: 2015 Dec 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2681–2687. doi: 10.1158/1055-9965.EPI-14-0490

Table 2. Study purpose, risk factors, registries, and funding, 31 SEER biospecimen studies, 2005–2013.

Attribute	Category	N	References
Study Purpose
	Etiology	19	(10–15, 17, 19, 20, 24, 26–29, 31, 33, 34, 37, 38)
	Prognosis	8	(8, 11, 14, 21–23, 35, 36)
	Detection, Development, Progression	6	(16, 18, 24, 33, 37, 38)
Risk Factors
	Human Papillomavirus	6	(14, 15, 17, 20, 31, 34)
	Tobacco	3	(10, 29, 31)
	Viral Hepatitis	2	(19, 33)
	Agricultural Chemical Exposure	2	(12, 13)
	Other (one each)^a	8	(10, 24, 26, 27, 28, 33, 37, 38)
Registries
	Hawaii	20	(8, 9, 14, 15, 17, 22, 24–27, 32–37)
	Iowa	19	(8, 10–17, 20, 21, 23, 29, 30, 34–36)
	Los Angeles	15	(8, 11, 13, 14, 17, 20, 21, 25, 26, 34–36, 38)
	Detroit, Kentucky, Seattle, Louisiana	5	(11, 13, 17, 20, 31)
	SEER/NPCR Collaboration	3	(17, 20, 34)
Funding
	SEER Contract	30	(8–30, 32–38)
	NCI Intramural Program	10	(9, 10, 12–14, 19, 25, 26, 28, 36)
	CDC NPCR	3	(17, 20, 34)
	Other^b	3	(15, 16,28-31)

Radon (10), soy intake (24), Epstein-Barr virus infection (26), parity (27), HIV infection (28), alcohol use (33), mammographic tissue density (37), and menopausal hormone therapy (38).

International Public and Private Consortium (15), NCI Office of HIV & AIDS Associated Malignancies (28), RO1 grant from NCI (16, 29, 30), NCI Rapid Response Surveillance Studies (31)